Intravenous artesunate for severe malaria
- PMID: 19492495
Intravenous artesunate for severe malaria
Abstract
(1) Plasmodium falciparum malaria can be fatal in non-immune individuals. Artemisinin derivatives are effective in the treatment of simple malaria attacks, but what is their role in treating severe malaria? (2) It has been estimated that intravenous quinine halves the mortality rate due to malaria. However, it has frequent dose-dependent adverse effects (tinnitus, hearing disorders, dizziness), and carries a risk of rare life-threatening reactions. Intravenous quinine has been a standard treatment for many years; (3) A very large trial has been conducted among adults and children in Southeast Asia. The mortality rate was lower with intravenous artesunate: 15% versus 22% with intravenous quinine. Other, smaller trials have provided similar results. The two treatments have similar adverse effects; (4) In practice, in Southeast Asia, intravenous artesunate has the best risk-benefit balance of the treatments available for severe malaria. Elsewhere, in the absence of parasite resistance, quinine remains the standard treatment. Comparisons with artesunate are awaited.
Similar articles
-
Artemisinin derivatives and malaria: useful, in combination with other antimalarials.Prescrire Int. 2008 Aug;17(96):162-8. Prescrire Int. 2008. PMID: 19492494
-
Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial.Clin Infect Dis. 2005 Jun 15;40(12):1777-84. doi: 10.1086/430309. Epub 2005 May 3. Clin Infect Dis. 2005. PMID: 15909266 Clinical Trial.
-
Artesunate, artemether or quinine in severe Plasmodium falciparum malaria?Expert Rev Anti Infect Ther. 2007 Apr;5(2):199-204. doi: 10.1586/14787210.5.2.199. Expert Rev Anti Infect Ther. 2007. PMID: 17402835 Review.
-
Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.Clin Infect Dis. 2006 Nov 15;43(10):1264-71. doi: 10.1086/508175. Epub 2006 Oct 12. Clin Infect Dis. 2006. PMID: 17051490 Clinical Trial.
-
Intravenous artesunate for the treatment of severe malaria.Ann Pharmacother. 2010 Jul-Aug;44(7-8):1250-8. doi: 10.1345/aph.1M732. Epub 2010 Jun 15. Ann Pharmacother. 2010. PMID: 20551300 Review.